New blood test and camera could spot breast cancer earlier, reduce unnecessary biopsies
NCT ID NCT06268405
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing two new ways to find breast cancer in women at high risk: a blood test that looks for tumor DNA and a special mammogram that uses a low-dose radioactive tracer. About 100 women who already need a biopsy will get both tests first. The goal is to see if these tools can help doctors see and understand breast abnormalities better than current methods, which could lead to fewer unnecessary biopsies and less worry.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Liquid Biopsy (blood test for tumor DNA) and Positron Emission Mammography (PEM) imaging device
What this could lead to
If successful, these tests could help radiologists spot breast cancer more accurately, potentially reducing unnecessary biopsies and anxiety for high-risk women.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply to all women. The tests are experimental and may not be more accurate than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact